Health Care [ 12/12 ] | Health Care Equipment & Supplies [ 43/74 ]
NASDAQ | Common Stock
Silk Road Medical, Inc operates as a medical device company in the United States.
The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR).
Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure.
The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
As of September 17, 2024, Silk Road Medical, Inc operates as a subsidiary of Boston Scientific Corporation.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 7, 24 | -0.42 Decreased by -20.00% | -0.38 Decreased by -10.53% |
| Apr 30, 24 | -0.36 Increased by +16.28% | -0.40 Increased by +10.00% |
| Feb 28, 24 | -0.33 Increased by +2.94% | -0.42 Increased by +21.43% |
| Nov 8, 23 | -0.33 Decreased by -13.79% | -0.35 Increased by +5.71% |
| Aug 1, 23 | -0.35 Increased by +18.60% | -0.39 Increased by +10.26% |
| May 9, 23 | -0.43 Increased by +10.42% | -0.39 Decreased by -10.26% |
| Feb 28, 23 | -0.34 Increased by +19.05% | -0.38 Increased by +10.53% |
| Nov 8, 22 | -0.29 Increased by +27.50% | -0.43 Increased by +32.56% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 24 | 51.24 M Increased by +13.12% | -16.60 M Decreased by -23.13% | Decreased by -32.40% Decreased by -8.85% |
| Mar 31, 24 | 48.48 M Increased by +20.81% | -14.14 M Increased by +11.71% | Decreased by -29.16% Increased by +26.92% |
| Dec 31, 23 | 47.27 M Increased by +17.97% | -13.01 M Decreased by -3.28% | Decreased by -27.52% Increased by +12.45% |
| Sep 30, 23 | 44.44 M Increased by +18.89% | -12.79 M Decreased by -12.06% | Decreased by -28.78% Increased by +5.75% |
| Jun 30, 23 | 45.30 M Increased by +36.55% | -13.48 M Increased by +12.43% | Decreased by -29.77% Increased by +35.87% |
| Mar 31, 23 | 40.13 M Increased by +43.22% | -16.01 M Increased by +4.01% | Decreased by -39.89% Increased by +32.98% |
| Dec 31, 22 | 40.07 M Increased by +41.77% | -12.60 M Increased by +14.26% | Decreased by -31.44% Increased by +39.52% |
| Sep 30, 22 | 37.37 M Increased by +51.31% | -11.41 M Increased by +17.81% | Decreased by -30.53% Increased by +45.68% |